Investments
1Partners & Customers
2About Norgenix
Norgenix, a wholly owned subsidiary of the J M Smith Corporation, is a North American specialty pharmaceutical, medical device, and biotech company that engages in the development, commercialization, and sales of pharmaceutical products in the women's health arena. Founded in 2008, Norgenix offers quality products that provide solutions to the unmet needs within women's health. With products spanning the continuum of care from pharmaceutical therapies to medical devices, Norgenix is licensed to sell, market, and distribute prescription drug products and medical devices in all 50 United States.
Want to inform investors similar to Norgenix about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Norgenix Investments
1 Investments
Norgenix has made 1 investments. Their latest investment was in viO HealthTech as part of their Seed VC on March 3, 2011.
Norgenix Investments Activity
Norgenix Partners & Customers
2 Partners and customers
Norgenix has 2 strategic partners and customers. Norgenix recently partnered with Femasys on August 8, 2011.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
8/16/2011 | Partner | United States | Norgenix To Distribution for FemVue Saline-Air Device. `` We are pleased to announce our partnership with Femasys Inc. , '' stated Ken Couch , President of Norgenix . | 2 | |
1/18/2011 | Partner |
Date | 8/16/2011 | 1/18/2011 |
|---|---|---|
Type | Partner | Partner |
Business Partner | ||
Country | United States | |
News Snippet | Norgenix To Distribution for FemVue Saline-Air Device. `` We are pleased to announce our partnership with Femasys Inc. , '' stated Ken Couch , President of Norgenix . | |
Sources | 2 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.